Steven Schmitt
Overview
Explore the profile of Steven Schmitt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
400
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bulbul E, Bode H, Schmitt S, Bozhuyuk K
Clin Transl Med
. 2025 Jan;
15(2):e70146.
PMID: 39856487
The eXchange Unit between Thiolation domains approach and artificial intelligence (AI)-driven tools like Synthetic Intelligence are transforming nonribosomal peptide synthetase and polyketide synthase engineering, enabling the creation of novel bioactive...
2.
Juskova P, Kling A, Schmitt S, Dittrich P
Methods Mol Biol
. 2024 May;
2804:179-194.
PMID: 38753148
Antibiotic susceptibility testing (AST) is a routine procedure in diagnostic laboratories to determine pathogen resistance profiles toward antibiotics. The need for fast and accurate resistance results is rapidly increasing with...
3.
Lo Re 3rd V, Price J, Schmitt S, Terrault N, Bhattacharya D, Arohnson A
Clin Infect Dis
. 2024 May;
PMID: 38752395
No abstract available.
4.
Lo Re 3rd V, Price J, Schmitt S, Terrault N, Bhattacharya D, Aronsohn A
Hepatology
. 2024 May;
80(1):3-7.
PMID: 38752360
No abstract available.
5.
Koch P, Schmitt S, Heynisch A, Gumpinger A, Wuthrich I, Gysin M, et al.
BMC Biol
. 2022 May;
20(1):114.
PMID: 35578204
Background: Intracellularly active antimicrobial peptides are promising candidates for the development of antibiotics for human applications. However, drug development using peptides is challenging as, owing to their large size, an...
6.
Koch P, Schmitt S, Cardner M, Beerenwinkel N, Panke S, Held M
Sci Rep
. 2022 Mar;
12(1):4097.
PMID: 35260685
The number of newly approved antimicrobial compounds has been steadily decreasing over the past 50 years emphasizing the need for novel antimicrobial substances. Here we present Me, a method for...
7.
Stucki A, Juskova P, Nuti N, Schmitt S, Dittrich P
Small Methods
. 2021 Dec;
5(8):e2100331.
PMID: 34927870
Microfluidic methods for the formation of single and double emulsion (DE) droplets allow for the encapsulation and isolation of reactants inside nanoliter compartments. Such methods have greatly enhanced the toolbox...
8.
Juskova P, Schmitt S, Armbrecht L, Dittrich P
Lab Chip
. 2021 Oct;
21(21):4071-4080.
PMID: 34618882
Microbial cells represent a standard production host for various important biotechnological products. Production yields can be increased by optimising strains and growth conditions and understanding deviations in production rates over...
9.
Juskova P, Schmitt S, Kling A, Rackus D, Held M, Egli A, et al.
ACS Sens
. 2021 Apr;
6(6):2202-2210.
PMID: 33900065
Rapid identification of a pathogen and the measurement of its antibiotic susceptibility are key elements in the diagnostic process of bacterial infections. Microfluidic technologies offer great control over handling and...
10.
Napiorkowska M, Pestalozzi L, Panke S, Held M, Schmitt S
Small
. 2020 Dec;
17(2):e2005523.
PMID: 33325637
Efficient production hosts are a key requirement for bringing biopharmaceutical and biotechnological innovations to the market. In this work, a truly universal high-throughput platform for optimization of microbial protein production...